Loading clinical trials...

CD4^LVFOXP3 in Participants With IPEX | Clinical Trials | Clareo Health

RECRUITINGPhase 1NCT05241444

CD4^LVFOXP3 in Participants With IPEX

This first-in-human, Phase 1 clinical trial will test the feasibility of the manufacturing and the safety of the administration of CD4\^LVFOXP3 in up to 30 evaluable human participants with IPEX and e...

Lead sponsor: Bacchetta, Rosa, MD•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Rosa Bacchetta, MD

CONTACT

650-498-8369 [email protected]

Related studies

RECRUITING

Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation

NCT04902807 · Autoimmune Lymphoproliferative Syndrome, Autoimmune Cytopenia, and more

COMPLETEDPhase 2

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

NCT01998633 · Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, and more

COMPLETEDNA

Effect of Dexmedetomidine on the Characteristics of High Volume/Low Concentration Ropivacaine in a Caudal Block in Pediatrics

NCT02163980 · Ambulatory Orchipexy

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 22, 2025Terms

Trial snapshot

StatusRECRUITING

PhasePHASE1

Enrollment30

Start dateMar 2022

Last updatedMay 22, 2025

Condition

IPEX

Locations shown

Lucile Packard Children's Hospital

Palo Alto, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 22, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions